Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsing Remitting Multiple Sclerosis RRMS”

186 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 186 results

Post-approval studies (Phase 4)Study completedNCT02499900
What this trial is testing

Study to Assess Medication Satisfaction in Patients With Relapsing Remitting Multiple Sclerosis Treated With Copaxone®

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 861
Large-scale testing (Phase 3)Study completedNCT00213135
What this trial is testing

A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
EMD Serono 1,326
Large-scale testing (Phase 3)Looking for participantsNCT07189325
What this trial is testing

A Prospective Randomized Non-inferiority Trial Comparing Anti-CD20 Maintenance Versus De-Escalation Strategy In Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis (RRMS)Anti-CD20 Therapy
University Hospital, Montpellier 250
Large-scale testing (Phase 3)Study completedNCT03774407
What this trial is testing

Vaginal Estriol in Multiple Sclerosis

Who this might be right for
Multiple SclerosisNeurogenic Bladder
Texas Tech University Health Sciences Center 21
Large-scale testing (Phase 3)Looking for participantsNCT07321093
What this trial is testing

The Efficacy and Safety of BCD-281 in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis (RRMS)
Biocad 292
Testing effectiveness (Phase 2)UnknownNCT02369926
What this trial is testing

Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Transparency Life Sciences 20
Large-scale testing (Phase 3)Active Not RecruitingNCT06700343
What this trial is testing

Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

Who this might be right for
Relapsing-remitting Multiple Sclerosis (RRMS)
Amgen 152
Testing effectiveness (Phase 2)Study completedNCT01051817
What this trial is testing

POC-MD MRI-based Trial in Relapsing-remitting Multiple Scler

Who this might be right for
Relapsing-remitting Multiple SclerosisRRMS
Novartis Pharmaceuticals 73
Not applicableEnded earlyNCT01905527
What this trial is testing

Adherence Trial With MS LifeLines ® Services

Who this might be right for
Multiple SclerosisRelapsing-Remitting
EMD Serono 306
Testing effectiveness (Phase 2)Study completedNCT06812585
What this trial is testing

The Effect of Metformin As an Adjuvant Therapy on Immunological Parameters in Egyptian Patients with RRMS: a Pilot Study

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
German University in Cairo 30
Post-approval studies (Phase 4)Study completedNCT00317941
What this trial is testing

Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Bayer 220
Not applicableStudy completedNCT01080053
What this trial is testing

Sexual Dysfunction, Disability and Quality of Life in Patients With Multiple Sclerosis (MS)

Who this might be right for
Multiple Sclerosis, Relapsing Remitting
Merck KGaA, Darmstadt, Germany 306
Large-scale testing (Phase 3)Study completedNCT00668343
What this trial is testing

Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Tehran University of Medical Sciences 80
Testing effectiveness (Phase 2)Study completedNCT00676715
What this trial is testing

The Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genentech, Inc. 220
Large-scale testing (Phase 3)Study completedNCT02525874
What this trial is testing

Effect of BG00012 on Lymphocyte Subsets and Immunoglobulins in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS).

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis
Biogen 218
Large-scale testing (Phase 3)Study completedNCT03093324
What this trial is testing

A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Biogen 506
Not applicableStudy completedNCT01456416
What this trial is testing

Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities

Who this might be right for
Relapsing Remitting Multiple Sclerosis
University of Southern California 10
Large-scale testing (Phase 3)Study completedNCT01838668
What this trial is testing

An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Relapsing-Remitting Multiple SclerosisMultiple Sclerosis
Biogen 225
Not applicableLooking for participantsNCT05177523
What this trial is testing

Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)Relapsing-remitting Multiple Sclerosis (RRMS)Secondary-progressive Multiple Sclerosis (SPMS)+1 more
University Hospital, Basel, Switzerland 300
Testing effectiveness (Phase 2)Ended earlyNCT02418325
What this trial is testing

Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genesis Limited 69
Next Page